Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG

NCT03067441 is registered in ClinicalTrials.gov with Esperion Therapeutics, Inc. as lead sponsor.

NCT NCT03067441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03067441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
Lead sponsor
Esperion Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 3, 2017
Completion date
November 5, 2019
Enrollment
1,462 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, hypercholesterolemia